Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Breast Cancer Research and Treatment|June 6, 2006
Pre-menopausal breast cancer and aromatase inhibitors: Treating a new generation of womenO C Freedman, S Verma, M J ClemonsCancer Treatment Reviews|February 15, 2005
Using aromatase inhibitors in the neoadjuvant setting: evolution or revolution?O C Freedman, S Verma, M J ClemonsClinical & Experimental Metastasis|March 7, 2009
Radiological changes following second-line zoledronic acid treatment in breast cancer patients with bone metastasesE Amir, C Whyne, O C Freedman, et al.Current Oncology (Toronto, Ont.)|August 11, 2010
Incidence of taxane-induced pain and distress in patients receiving chemotherapy for early-stage breast cancer: a retrospective, outcomes-based surveyS Saibil, B Fitzgerald, O C Freedman, et al.Current Oncology (Toronto, Ont.)|April 8, 2015
Adjuvant endocrine therapy for early breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guidelineO C Freedman, G G Fletcher, S Gandhi, et al.Current Oncology (Toronto, Ont.)|April 8, 2015
Optimal systemic therapy for early breast cancer in women: a clinical practice guidelineA Eisen, G G Fletcher, S Gandhi, et al.Current Oncology (Toronto, Ont.)|April 8, 2015
Adjuvant chemotherapy for early female breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guidelineS Gandhi, G G Fletcher, A Eisen, et al.Current Oncology (Toronto, Ont.)|April 8, 2015
Systemic targeted therapy for her2-positive early female breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guidelineM Mates, G G Fletcher, O C Freedman, et al.Gynecologic Oncology|July 2, 2010
Diagnosis of epithelial ovarian carcinoma prior to neoadjuvant chemotherapyO C Freedman, J Dodge, P Shaw, et al.Breast Cancer Research and Treatment|September 5, 2009
A randomized trial exploring the biomarker effects of neoadjuvant sequential treatment with exemestane and anastrozole in post-menopausal women with hormone receptor-positive breast cancerO C Freedman, E Amir, W Hanna, et al.Pageof 2